Tech Company Financing Transactions

Phil Funding Round

Greatpoint Ventures Innovation Fund, Crosslink Capital and Tarsadia Investments participated in a $25 million Series B funding round for Phil. The round closed on 5/16/2019.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

234 Front St. 4th Floor
San Francisco, CA 94111
USA

Phone

(855) 977-0975

Website

www.phil.us

Email Address

[email protected]

Overview

We started Phil with the simple conviction that the medications we take should improve our sense of wellbeing. In other words, we should not have to suffer through an inconvenient, stressful and archaic experience to ensure a consistent supply of our medications. As folks who take recurring prescriptions ourselves, we decided to do something about it: we started Phil.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Deepak Thomas

        

Browse more venture capital transactions:

Prev: 5/16/2019: Novi venture capital transaction
Next: 5/16/2019: ClearFlow venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary